Researchers search for better timing to treat Stroke's immune response
NCT ID NCT02900833
Summary
This study aims to understand how a specific type of immune cell (neutrophils) behaves over time in people having a stroke. Researchers will observe 440 stroke patients who are already receiving a standard clot-removal procedure. The goal is to learn when these cells become harmful after a stroke, which could help design better future treatments that target them at the right moment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE STROKE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fondation Ophtalmologique Adolphe de Rothschild
Paris, 75019, France
Conditions
Explore the condition pages connected to this study.